secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcus Biosciences, Inc. (RCUS)
CIK:        0001724521
Form:       8-K
Filed at:   2026-06-12T20:12:40+00:00
Accession:  0001724521-26-000037
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arcus Biosciences stockholders elect four Class II directors, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- Elected Class II directors: Dietmar Berger (85.9M for), David Lacey (86.0M), Nicole Lambert (92.7M), Johanna Mercier (85.9M); ~13.6M broker non-votes.
- Ratified Ernst & Young as auditor for FY2026: 112.9M for, 4.8M against, 0.2M abstain.
- Advisory say-on-pay approved: 94.9M for, 9.3M against, 29.7K abstain; 13.6M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724521/000172452126000037/0001724521-26-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724521/000172452126000037/rcus-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001724521-26-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer